held a groundbreaking ceremony on the 30th at its Ochang branch for the expansion of its animal biosafety level 3 (ABL3) research facility, which is capable of conducting primate experiments.

Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), today announced the ...

"By investing in state-of-the-art BSL-2 and BSL-3 facilities, expanding technical capabilities, and further strengthening our scientific teams, we are uniquely positioned to deliver high-quality ...

The 2022 monkeypox outbreak has revived international scrutiny over the safety and transparency of high-containment laboratories.

Once up and running, the institute will reduce the state’s dependency on NIV especially during outbreaks of viral diseases ...